Avidin/Biotin Blocking Kit

SP-2001

SKU	Unit Size	Price	Qty
SP-2001	1 kit	$145.00 See our distributors

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Technical Information

Description

Avidin/Biotin Blocking Kit blocks all endogenous biotin, biotin receptors, and avidin binding sites present in tissues. This kit is designed for use with avidin detection systems such as the VECTASTAIN^® ABC Kits if avidin or biotinylated reagents bind non-specifically to tissues or proteins.

This blocking kit consists of 18 ml of Avidin D and 18 ml of biotin in convenient dropper bottles.

Specifications

More Information
Unit Size	1 kit
Applications	Immunohistochemistry / Immunocytochemistry, Immunofluorescence, In situ hybridization, Blotting Applications, Elispot
Blocking Action	Endogenous Biotin or Avidin/Streptavidin Binding Proteins
Format	Ready-to-Use

Documents

Product FAQs

What is the difference between the Avidin/Biotin Blocking Kit, Cat. No. SP-2001, and the Streptavidin/Biotin Blocking Kit, Cat. No. SP-2002, and can they be used interchangeably?

These kits were developed to prevent non-specific binding of avidin or streptavidin based detection reagents primarily to endogenous biotin in cell and tissue IHC and IF applications. It is generally recommended to match the blocking and detection reagent such as using an avidin/biotin blocking kit with an avidin based detection system. In most cases, however, these kits can be used interchangeably, except in circumstances where avidin or streptavidin may bind to inherent non-biotin associated structures (see: Alon, R., et al {1992}, Eur. J. Cell Biol. 58:271-279).

Do I have to apply the avidin/biotin blocking kit reagents before the primary antibody?

If the primary antibody is unconjugated, then the avidin/biotin blocking kit reagents can be applied at any time prior to the application of the biotinylated secondary antibody. If the primary antibody is biotinylated, then we would recommend applying the avidin/biotin blocking kit reagents before primary antibody incubation.